VEGFA and age-related macular degeneration: More recently, in a mouse model of laser-induced CNV simulating the neovascular stage of AMD, oral treatment with a pro-drug of EGCG significantly alleviated mouse laser-induced CNV leakage and reduced CNV area by down-regulating the HIF-1α/VEGF/VEGFR2 pathway [171].